Top

Published in:

01-01-2016 | Original Article

E-cadherin increasing multidrug resistance protein 1 via hypoxia-inducible factor-1α contributes to multicellular resistance in colorectal cancer

Authors: Xi Liang, Xueqing Xu, Fengchao Wang, Ni Li, Jianming He

Published in: Tumor Biology | Issue 1/2016

Abstract

When cancer cells have been cultured as three-dimensional (3D) cultures or in vivo, they decrease sensitivity to anticancer drugs. This is called multicellular resistance, and the mechanism is not fully understood. Here, we report that E-cadherin increasing multidrug resistance protein 1 (MDR1) via hypoxia-inducible factor-1α (HIF-1α) contributes to multicellular resistance in colorectal cancer. The MDR1 protein level was higher in 3D cultures than in monolayer cells. When dispersed cells from 3D cultures were grown as monolayer cells again, the MDR1 protein level decreased to the similar level of cells maintained as monolayer all through. Knockdown of MDR1 significantly decreased multicellular resistance. Knockdown of E-cadherin decreased MDR1 in 3D cultures but did not detectably change MDR1 in monolayer cells. E-cadherin was expressed uniformly in 3D cultures while the MDR1 protein level was higher in the center of 3D cultures than in the peripheral part. Knockdown of E-cadherin decreased E-cadherin uniformly in 3D cultures but mainly decreased MDR1 at the center of 3D cultures. These suggest that knockdown of E-cadherin decreasing MDR1 may be by an indirect mechanism. HIF-1α was remarkably increased in 3D cultures. Knockdown of E-cadherin decreased intercellular junctions, increased intercellular space, and decreased HIF-1α in 3D cultures. Knockdown of HIF-1α decreased MDR1 in 3D cultures. Knockdown of E-cadherin increased β-catenin uniformly in 3D cultures, and knockdown of β-catenin decreased MDR1 what was opposite to knockdown of E-cadherin decreasing MDR1. Our data reveal that knockdown of E-cadherin decreasing MDR1 via HIF-1α is involved in the mechanism of multicellular resistance in colorectal cancer. Though β-catenin is also involved in the mechanism, it does not play a dominant role.

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.21262.CrossRefPubMed

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29. doi:10.3322/caac.21254.CrossRefPubMed

He J, Shin H, Wei X, Kadegowda AK, Chen R, Xie SK. NPC1L1 knockout protects against colitis-associated tumorigenesis in mice. BMC Cancer. 2015;15:189. doi:10.1186/s12885-015-1230-0.CrossRefPubMedPubMedCentral

Kolosenko I, Fryknas M, Forsberg S, Johnsson P, Cheon H, Holvey-Bates EG, et al. Cell crowding induces interferon regulatory factor 9, which confers resistance to chemotherapeutic drugs. Int J Cancer. 2015;136(4):E51–61. doi:10.1002/ijc.29161.CrossRefPubMed

Zhan X, Feng X, Kong Y, Chen Y, Tan W. JNK signaling maintains the mesenchymal properties of multi-drug resistant human epidermoid carcinoma KB cells through snail and twist1. BMC Cancer. 2013;13:180. doi:10.1186/1471-2407-13-180.CrossRefPubMedPubMedCentral

Desoize B, Jardillier J. Multicellular resistance: a paradigm for clinical resistance? Crit Rev Oncol Hematol. 2000;36(2–3):193–207.CrossRefPubMed

Wang CF, Wang YQ, Huang FZ, Nie WP, Liu XY, Jiang XZ. Association between reversal of multidrug resistance by methyl jasmonate and P-glycoprotein ATPase activity in hepatocellular carcinoma. J Int Med Res. 2013;41(4):964–74. doi:10.1177/0300060513483401.CrossRefPubMed

Seebacher NA, Richardson DR, Jansson PJ. Glucose modulation induces reactive oxygen species and increases P-glycoprotein-mediated multidrug resistance to chemotherapeutics. Br J Pharmacol. 2015;172(10):2557–72. doi:10.1111/bph.13079.CrossRefPubMedPubMedCentral

Longati P, Jia X, Eimer J, Wagman A, Witt MR, Rehnmark S, et al. 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing. BMC Cancer. 2013;13:95. doi:10.1186/1471-2407-13-95.CrossRefPubMedPubMedCentral

10.

Durand RE. Chemosensitivity testing in V79 spheroids: drug delivery and cellular microenvironment. J Natl Cancer Inst. 1986;77(1):247–52.PubMed

11.

Durand RE. Distribution and activity of antineoplastic drugs in a tumor model. J Natl Cancer Inst. 1989;81(2):146–52.CrossRefPubMed

12.

He JM, Wang FC, Qi HB, Li Y, Liang HJ. Down-regulation of alphav integrin by retroviral delivery of small interfering RNA reduces multicellular resistance of HT29. Cancer Lett. 2009;284(2):182–8. doi:10.1016/j.canlet.2009.04.023.CrossRefPubMed

13.

Haga T, Uchide N, Tugizov S, Palefsky JM. Role of E-cadherin in the induction of apoptosis of HPV16-positive CaSki cervical cancer cells during multicellular tumor spheroid formation. Apoptosis. 2008;13(1):97–108. doi:10.1007/s10495-007-0132-2.CrossRefPubMed

14.

Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 2008;68(10):3645–54. doi:10.1158/0008-5472.CAN-07-2938.CrossRefPubMed

15.

Pryczynicz A, Guzinska-Ustymowicz K, Niewiarowska K, Cepowicz D, Kemona A. PRL-3 and E-cadherin show mutual interactions and participate in lymph node metastasis formation in gastric cancer. Tumour Biol. 2014. doi:10.1007/s13277-014-1855-7.

16.

Luo M, Li Z, Wang W, Zeng Y, Liu Z, Qiu J. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett. 2013;333(2):213–21. doi:10.1016/j.canlet.2013.01.033.CrossRefPubMed

17.

Linn SC, Honkoop AH, Hoekman K, van der Valk P, Pinedo HM, Giaccone G. p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer. Br J Cancer. 1996;74(1):63–8.CrossRefPubMedPubMedCentral

18.

Comerford KM, Cummins EP, Taylor CT. c-Jun NH2-terminal kinase activation contributes to hypoxia-inducible factor 1alpha-dependent P-glycoprotein expression in hypoxia. Cancer Res. 2004;64(24):9057–61. doi:10.1158/0008-5472.CAN-04-1919.CrossRefPubMed

19.

Burger H, Foekens JA, Look MP, Meijer-van Gelder ME, Klijn JG, Wiemer EA, et al. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response. Clin Cancer Res. 2003;9(2):827–36.PubMed

20.

Ding Z, Yang L, Xie X, Xie F, Pan F, Li J, et al. Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cells. J Cancer Res Clin Oncol. 2010;136(11):1697–707. doi:10.1007/s00432-010-0828-5.CrossRefPubMedPubMedCentral

21.

Katayama K, Yamaguchi M, Noguchi K, Sugimoto Y. Protein phosphatase complex PP5/PPP2R3C dephosphorylates P-glycoprotein/ABCB1 and down-regulates the expression and function. Cancer Lett. 2014;345(1):124–31. doi:10.1016/j.canlet.2013.12.007.CrossRefPubMed

22.

Hinoshita E, Uchiumi T, Taguchi K, Kinukawa N, Tsuneyoshi M, Maehara Y, et al. Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas. Clin Cancer Res. 2000;6(6):2401–7.PubMed

23.

Mechetner EB, Roninson IB. Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody. Proc Natl Acad Sci U S A. 1992;89(13):5824–8.CrossRefPubMedPubMedCentral

24.

Doublier S, Belisario DC, Polimeni M, Annaratone L, Riganti C, Allia E, et al. HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast. BMC Cancer. 2012;12:4. doi:10.1186/1471-2407-12-4.CrossRefPubMedPubMedCentral

25.

Lim JC, Kania KD, Wijesuriya H, Chawla S, Sethi JK, Pulaski L, et al. Activation of beta-catenin signalling by GSK-3 inhibition increases p-glycoprotein expression in brain endothelial cells. J Neurochem. 2008;106(4):1855–65. doi:10.1111/j.1471-4159.2008.05537.x.PubMedPubMedCentral

26.

van Rensburg CE, Joone GK, O’Sullivan JF. Clofazimine and B4121 sensitize an intrinsically resistant human colon cancer cell line to P-glycoprotein substrates. Oncol Rep. 2000;7(1):193–5.PubMed

27.

Li Y, He J, Zhong D, Li J, Liang H. High-mobility group box 1 protein activating nuclear factor-kappaB to upregulate vascular endothelial growth factor C is involved in lymphangiogenesis and lymphatic node metastasis in colon cancer. J Int Med Res. 2015. doi:10.1177/0300060515581671.

28.

Phung YT, Barbone D, Broaddus VC, Ho M. Rapid generation of in vitro multicellular spheroids for the study of monoclonal antibody therapy. J Cancer. 2011;2:507–14.CrossRefPubMedPubMedCentral

29.

Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc. 2006;1(5):2315–9. doi:10.1038/nprot.2006.339.CrossRefPubMed

30.

Yang S, Thor AD, Edgerton S, Yang X. Caspase-3 mediated feedback activation of apical caspases in doxorubicin and TNF-alpha induced apoptosis. Apoptosis. 2006;11(11):1987–97. doi:10.1007/s10495-006-0084-y.CrossRefPubMed

31.

Yan SX, Luo XM, Zhou SH, Bao YY, Fan J, Lu ZJ, et al. Effect of antisense oligodeoxynucleotides glucose transporter-1 on enhancement of radiosensitivity of laryngeal carcinoma. Int J Med Sci. 2013;10(10):1375–86. doi:10.7150/ijms.6855.CrossRefPubMedPubMedCentral

32.

Solanas G, Porta-de-la-Riva M, Agusti C, Casagolda D, Sanchez-Aguilera F, Larriba MJ, et al. E-cadherin controls beta-catenin and NF-kappaB transcriptional activity in mesenchymal gene expression. J Cell Sci. 2008;121(Pt 13):2224–34. doi:10.1242/jcs.021667.CrossRefPubMed

33.

Laurent J, Frongia C, Cazales M, Mondesert O, Ducommun B, Lobjois V. Multicellular tumor spheroid models to explore cell cycle checkpoints in 3D. BMC Cancer. 2013;13:73. doi:10.1186/1471-2407-13-73.CrossRefPubMedPubMedCentral

34.

Ge X, Zhen F, Yang B, Yang X, Cai J, Zhang C, et al. Ginsenoside Rg3 enhances radiosensitization of hypoxic oesophageal cancer cell lines through vascular endothelial growth factor and hypoxia inducible factor 1alpha. J Int Med Res. 2014;42(3):628–40. doi:10.1177/0300060513505491.CrossRefPubMed

35.

Kihira Y, Yamano N, Izawa-Ishizawa Y, Ishizawa K, Ikeda Y, Tsuchiya K, et al. Basic fibroblast growth factor regulates glucose metabolism through glucose transporter 1 induced by hypoxia-inducible factor-1alpha in adipocytes. Int J Biochem Cell Biol. 2011;43(11):1602–11. doi:10.1016/j.biocel.2011.07.009.CrossRefPubMed

36.

Yun JA, Kim SH, Hong HK, Yun SH, Kim HC, Chun HK, et al. Loss of E-Cadherin expression is associated with a poor prognosis in stage III colorectal cancer. Oncology. 2014;86(5–6):318–28. doi:10.1159/000360794.CrossRefPubMed

Title: E-cadherin increasing multidrug resistance protein 1 via hypoxia-inducible factor-1α contributes to multicellular resistance in colorectal cancer
Authors: Xi Liang
Xueqing Xu
Fengchao Wang
Ni Li
Jianming He
Publication date: 01-01-2016
Publisher: Springer Netherlands
Published in: Tumor Biology / Issue 1/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-015-3811-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2016

FoxP3 in papillary thyroid carcinoma induces NIS repression through activation of the TGF-β1/Smad signaling pathway

Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer

Transforming growth factor-β signaling pathway cross-talking with ERα signaling pathway on regulating the growth of uterine leiomyoma activated by phenolic environmental estrogens in vitro

PTEN gene polymorphisms and susceptibility to oral squamous cell carcinoma in a Chinese Han population

ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients

MicroRNAs as biomarkers and prospective therapeutic targets in colon and pancreatic cancers

Keynote webinar | Spotlight on antibody–drug conjugates in cancer